The importance of an independent validation cohort for metabolomics biomarker studies

Mov Disord. 2018 May;33(5):856. doi: 10.1002/mds.27374. Epub 2018 May 3.

Authors

Jean-Pierre Trezzi^{1

2}, Karsten Hiller^{3

4}, Brit Mollenhauer⁵

Affiliations

¹ Integrated Biobank of Luxembourg, Dudelange, Luxembourg.
² Luxembourg Center for Systems Biomedicine, avenue de l'Université, Esch-sur-Alzette, Luxembourg.
³ Braunschweig Integrated Centre for Systems Biology (BRICS), Technische Universität Braunschweig, Germany.
⁴ Helmholtz Centre for Infection Research, Braunschweig, Germany.
⁵ Paracelsus-Elena Klinik, Kassel and University Medical Center, Goettingen, Germany.

PMID: 29722455
DOI: 10.1002/mds.27374

No abstract available

Publication types

Letter
Comment

MeSH terms

Biomarkers
Cohort Studies
Humans
Metabolomics*
Parkinson Disease*

Substances

Biomarkers